4.7 Article

Comparative analysis of machine learning algorithms on the microbial strain-specific AMP prediction

Journal

BRIEFINGS IN BIOINFORMATICS
Volume 23, Issue 4, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbac233

Keywords

antimicrobial peptides; AMP prediction; machine learning

Funding

  1. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services
  2. International Science and Technology Center [G-2102]

Ask authors/readers for more resources

The evolution of drug-resistant microbial species is a global health concern. Antimicrobial peptides (AMPs) are potential candidates for addressing antibiotic resistance, and computational methods have been developed to predict their activity. However, most methods are not strain-specific, and only a few models have been developed due to limited data. To improve predictions, a novel approach based on AMP sequences and target microbial genome characteristics was developed. The new models, using machine learning algorithms, showed improved performance compared to sequence-based models. The MSS AMP predictor is freely accessible as part of the DBAASP database.
The evolution of drug-resistant pathogenic microbial species is a major global health concern. Naturally occurring, antimicrobial peptides (AMPs) are considered promising candidates to address antibiotic resistance problems. A variety of computational methods have been developed to accurately predict AMPs. The majority of such methods are not microbial strain specific (MSS): they can predict whether a given peptide is active against some microbe, but cannot accurately calculate whether such peptide would be active against a particular MS. Due to insufficient data on most MS, only a few MSS predictive models have been developed so far. To overcome this problem, we developed a novel approach that allows to improve MSS predictive models (MSSPM), based on properties, computed for AMP sequences and characteristics of genomes, computed for target MS. New models can perform predictions of AMPs for MS that do not have data on peptides tested on them. We tested various types of feature engineering as well as different machine learning (ML) algorithms to compare the predictive abilities of resulting models. Among the ML algorithms, Random Forest and AdaBoost performed best. By using genome characteristics as additional features, the performance for all models increased relative to models relying on AMP sequence-based properties only. Our novel MSS AMP predictor is freely accessible as part of DBAASP database resource at http://dbaasp.org/prediction/genome

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available